{"product_id":"braf-antibody-sc-f3765","title":"BRAF Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eThe BRAF gene, located on chromosome 7q34, encodes a serine\/threonine protein kinase that is a central component of the MAP kinase\/ERK signaling pathway. This pathway governs key cellular processes, including growth, proliferation, differentiation, senescence, and apoptosis. Within the Ras\/Raf\/MEK\/ERK cascade, BRAF functions as a direct downstream effector of RAS, becoming activated through dimerization. Depending on the literature source, BRAF may also be discussed as BRAF1 and RAFB1.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane and cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following BRAF across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eBRAF is commonly interpreted in the context of cancer, developmental biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane and cytoplasm across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003estage-dependent patterns during differentiation, morphogenesis, or lineage commitment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for BRAF. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in BRAF reflect biology rather than handling. When interpreting BRAF, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep BRAF trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578045309273,"sku":"F3765-20UL","price":189.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578045342041,"sku":"F3765-100UL","price":379.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578045374809,"sku":"F3765-2X100UL","price":569.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3765-wb.gif?v=1773601458","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/braf-antibody-sc-f3765","provider":"Absource Diagnostics","version":"1.0","type":"link"}